1. Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications. Issue 9 (23rd July 2013) Authors: Pavlik, Tomas; Janousova, Eva; Mayer, Jiri; Indrak, Karel; Jarosova, Marie; Klamova, Hana; Zackova, Daniela; Voglova, Jaroslava; Faber, Edgar; Karas, Michal; Machova Polakova, Katerina; Racil, Zdenek; Demeckova, Eva; Demitrovicova, Ludmila; Tothova, Elena; Chudej, Juraj; Markuljak, Imrich; Cmunt,... Journal: American journal of hematology Issue: Volume 88:Issue 9(2013:Sep.) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. Issue 10 (October 2013) Authors: Zackova, Daniela; Klamova, Hana; Muzik, Jan; Cmunt, Eduard; Racil, Zdenek; Machova Polakova, Katerina; Dvorakova, Dana; Jurcek, Tomas; Razga, Filip; Cetkovsky, Petr; Dusek, Ladislav; Mayer, Jiri Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of 5‐year imatinib treatment of 458 patients with CP‐CML in routine clinical practice and prognostic impact of different BCR‐ABL cutoff levels. (21st February 2013) Authors: Klamová, Hana; Poláková, Kateřina Machová; Mužík, Jan; Ráčil, Zdeněk; Žáčková, Daniela; Steinerová, Kateřina; Karas, Michal; Faber, Edgar; Demečková, Eva; Michalovičová‐Sninská, Zuzana; Voglová, Jaroslava; Demitrovičová, Ľudmila; Mikušková, Eva; Tóthová, Elena; Chudej, Juraj; Markuljak, Imrich; C... Journal: Cancer medicine Issue: Volume 2:Number 2(2013:Apr.) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. (June 2019) Authors: Belohlavkova, Petra; Steinerova, Katerina; Karas, Michal; Skoumalova, Iva; Rohon, Peter; Indrak, Karel; Voglova, Jaroslava; Vrbacky, Filip; Cmunt, Eduard; Necasova, Tereza; Kristkova, Zlatuse; Trneny, Marek; Zak, Pavel; Papajik, Tomas; Faber, Edgar Journal: Leukemia research Issue: Volume 81(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). (June 2018) Authors: Jonasova, Anna; Neuwirtova, Radana; Polackova, Helena; Siskova, Magda; Stopka, Tomas; Cmunt, Eduard; Belickova, Monika; Moudra, Alena; Minarik, Lubomir; Fuchs, Ota; Michalova, Kyra; Zemanova, Zuzana Journal: Leukemia research Issue: Volume 69(2018) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group. (22nd February 2021) Authors: Smolej, Lukáš; Brychtová, Yvona; Cmunt, Eduard; Doubek, Michael; Špaček, Martin; Belada, David; Šimkovič, Martin; Stejskal, Lukáš; Zygulová, Irena; Urbanová, Renata; Brejcha, Martin; Zuchnická, Jana; Móciková, Heidi; Kozák, Tomáš Journal: British journal of haematology Issue: Volume 193:Number 4(2021) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab. (April 2019) Authors: Špaček, Martin; Obrtlíková, Petra; Hrobková, Stanislava; Cmunt, Eduard; Karban, Josef; Molinský, Jan; Šimkovič, Martin; Mociková, Heidi; Mohammadová, Lekaa; Panovská, Anna; Novák, Jan; Trněný, Marek; Smolej, Lukáš; Doubek, Michael Journal: Leukemia research Issue: Volume 79(2019) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Thrombosis in thrombocythemic Ph‐ myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide. (21st April 2015) Authors: Schwarz, Jiří; Ovesná, Petra; Černá, Olga; Kissová, Jarmila; Soukupová, Jacqueline Maaloufová; Brychtová, Yvona; Doubek, Michael; Červinek, Libor; Cmunt, Eduard; Dulíček, Petr; Campr, Vít; Křen, Leoš; Penka, Miroslav Journal: European journal of haematology Issue: Volume 96:Number 1(2016:Jan.) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗